17.11.2014 Views

Stem Cell Mobilization - CBMTG

Stem Cell Mobilization - CBMTG

Stem Cell Mobilization - CBMTG

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Strategy 3 : Plerixafor decision based on actual<br />

mobilization of CD34+ cells after 4 days of G-CSF<br />

Advantages<br />

Disadvantages<br />

Reduced need for<br />

remobilization<br />

Lower number of apheresis<br />

sessions<br />

High rate of plerixafor utilization<br />

(~40-70%)<br />

Need for stat CD34+ count<br />

Avoid unnecessary use of<br />

plerixafor in patients with<br />

adequate G-CSF mobilization<br />

Lower growth-factor,<br />

apheresis and<br />

cryopreservation costs<br />

Improved transplant center<br />

“flow” (predictability)<br />

10

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!